Proposal Brief
Icon

Industry

Pharmaceuticals

Icon

Sub Industry

Contract Research & Manufacturing Services (CRAMS)

Icon

Deal Size

INR 50 - 500 Cr

Icon

Preferred Location

India

Icon

Region

Across India

Icon

Open for Distressed Assets

No

Target Requirement

The Company is seeking acquisition targets in the CRO and/or CDMO space with the following criteria-

 

CROs

  • Advanced Research for regulated markets (US, Europe, Japan), targeting the innovator segment, not the generics,
  • Readiness to get into intermediate / API manufacturing,
  • Not interested in companies engaged in BA / BE studies or drug trials,
  • Financial metrics:
    • Revenue: $ 2.5 Mn - $ 10 Mn,
    • Minimum EBITDA Margin: 20%

 

CDMOs

  • Manufacturing for regulated markets (US, Europe, Japan), targeting the innovator segment, not the generics,
  • Specializing in chemical development, pharma intermediates,
  • Not interested in: Formulations, Companies with weak R&D, pure play API manufacturers,
  • Financial metrics:
    • Revenue: $ 4 Mn - $ 15 Mn
    • Minimum EBITDA Margin: 15%

 

Acquisition preferences:

  • Strong client relationships with innovators from US, Europe and/or Japan (ideally)
  • Very keen on control transactions in cash

Business Operation Information
Business Documents